AURX — Nuo Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $35.39m
- $34.46m
- $0.61m
Annual cashflow statement for Nuo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.19 | -0.091 | -0.091 | -3.17 | -3.17 |
| Depreciation | |||||
| Non-Cash Items | 0.168 | 0.025 | 0.014 | 0.009 | 0.022 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.015 | 0.012 | -0.043 | -0.55 | -0.033 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.922 | -0.054 | -0.12 | -3.71 | -3.17 |
| Capital Expenditures | — | 0 | 0 | -0.06 | -0.007 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | -0.06 | -0.007 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.305 | 0.195 | 1.37 | 4.46 | 2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.617 | 0.141 | 1.25 | 0.692 | -1.18 |